Prostatic Artery Embolization: A Systematic Review Article

Abstract

Since the first case report in 2000, there has been a rapid expansion of prostatic artery embolization (PAE) as a therapy for symptomatic benign prostatic hyperplasia. The published literature and clinical experience show that this procedure is safe and effective. This article discusses the brief history, current issues in technique, and the state of the literature regarding outcomes of PAE. Current and future research topics are also discussed.

Keywords

prostatic artery embolization - benign prostatic hyperplasia - International Prostate Symptom Score

Publication History

Article published online:
24 October 2024

• References

• 1 Egan KB. The epidemiology of benign prostatic hyperplasia associated with lower urinary tract symptoms: prevalence and incident rates. Urol Clin North Am 2016; 43 (03) 289-297
• 2 Parsons JK. Benign prostatic hyperplasia and male lower urinary tract symptoms: epidemiology and risk factors. Curr Bladder Dysfunct Rep 2010; 5 (04) 212-218
• 3 Cornelis FH, Bilhim T, Hacking N, Sapoval M, Tapping CR, Carnevale FC. CIRSE standards of practice on prostatic artery embolisation. Cardiovasc Intervent Radiol 2020; 43 (02) 176-185
• 4 Mitchell ME, Waltman AC, Athanasoulis CA, Kerr Jr WS, Dretler SP. Control of massive prostatic bleeding with angiographic techniques. J Urol 1976; 115 (06) 692-695
• 5 Bischoff W, Goerttler U. [Successful intra-arterial embolization of bleeding carcinoma of the prostate (author's transl)]. Urologe A 1977; 16 (02) 99-102
• 6 Michel F, Dubruille T, Cercueil JP, Paparel P, Cognet F, Krause D. Arterial embolization for massive hematuria following transurethral prostatectomy. J Urol 2002; 168 (06) 2550-2551
• 7 Rastinehad AR, Caplin DM, Ost MC. et al. Selective arterial prostatic embolization (SAPE) for refractory hematuria of prostatic origin. Urology 2008; 71 (02) 181-184
• 8 DeMeritt JS, Elmasri FF, Esposito MP, Rosenberg GS. Relief of benign prostatic hyperplasia-related bladder outlet obstruction after transarterial polyvinyl alcohol prostate embolization. J Vasc Interv Radiol 2000; 11 (06) 767-770
• 9 Sun F, Sánchez FM, Crisóstomo V. et al. Benign prostatic hyperplasia: transcatheter arterial embolization as potential treatment–preliminary study in pigs. Radiology 2008; 246 (03) 783-789
• 10 Sun F, Sánchez FM, Crisóstomo V. et al. Transarterial prostatic embolization: initial experience in a canine model. AJR Am J Roentgenol 2011; 197 (02) 495-501
• 11 Carnevale FC, Antunes AA, da Motta Leal Filho JM. et al. Prostatic artery embolization as a primary treatment for benign prostatic hyperplasia: preliminary results in two patients. Cardiovasc Intervent Radiol 2010; 33 (02) 355-361
• 12 Pisco JM, Pinheiro LC, Bilhim T, Duarte M, Mendes JR, Oliveira AG. Prostatic arterial embolization to treat benign prostatic hyperplasia. J Vasc Interv Radiol 2011; 22 (01) 11-19 , quiz 20
• 13 Pisco J, Campos Pinheiro L, Bilhim T. et al. Prostatic arterial embolization for benign prostatic hyperplasia: short- and intermediate-term results. Radiology 2013; 266 (02) 668-677
• 14 Pisco JM, Rio Tinto H, Campos Pinheiro L. et al. Embolisation of prostatic arteries as treatment of moderate to severe lower urinary symptoms (LUTS) secondary to benign hyperplasia: results of short- and mid-term follow-up. Eur Radiol 2013; 23 (09) 2561-2572
• 15 Carnevale FC, da Motta-Leal-Filho JM, Antunes AA. et al. Quality of life and symptoms relief support prostatic artery embolization for patients with acute urinary retention due to benign prostatic hyperplasia. J Vasc Interv Radiol 2012; 24: 535-542
• 16 Bagla S, Martin CP, van Breda A. et al. Early results from a United States trial of prostatic artery embolization in the treatment of benign prostatic hyperplasia. J Vasc Interv Radiol 2014; 25 (01) 47-52
• 17 Gao YA, Huang Y, Zhang R. et al. Benign prostatic hyperplasia: prostatic arterial embolization versus transurethral resection of the prostate–a prospective, randomized, and controlled clinical trial. Radiology 2014; 270 (03) 920-928
• 18 Pereira K, Halpern JA, McClure TD. et al. Role of prostate artery embolization in the management of refractory haematuria of prostatic origin. BJU Int 2016; 118 (03) 359-365
• 19 Chen JW, Shin JH, Tsao TF. et al. Prostatic arterial embolization for control of hematuria in patients with advanced prostate cancer. J Vasc Interv Radiol 2017; 28 (02) 295-301
• 20 Ayyagari R, Powell T, Staib L. et al. Prostatic artery embolization in nonindex benign prostatic hyperplasia patients: single-center outcomes for urinary retention and gross prostatic hematuria. Urology 2020; 136: 212-217
• 21 Malling B, Røder MA, Lindh M, Frevert S, Brasso K, Lönn L. Palliative prostate artery embolization for prostate cancer: a case series. Cardiovasc Intervent Radiol 2019; 42 (10) 1405-1412
• 22 Bhatia S, Sinha VK, Kava BR. et al. Efficacy of prostatic artery embolization for catheter-dependent patients with large prostate sizes and high comorbidity scores. J Vasc Interv Radiol 2018; 29 (01) 78-84.e1
• 23 Rampoldi A, Barbosa F, Secco S. et al. Prostatic artery embolization as an alternative to indwelling bladder catheterization to manage benign prostatic hyperplasia in poor surgical candidates. Cardiovasc Intervent Radiol 2017; 40 (04) 530-536
• 24 Tapping CR, Boardman P. Prostatic artery embolization (PAE) in catheter-dependent patients with large prostatic (BPH) glands (>90 cc): early intervention essential. Acta Radiol 2019; 60 (11) 1562-1565
• 25 Kably I, Pereira K, Chong W, Bhatia S. Prostate artery embolization (PAE) in the management of refractory hematuria of prostatic origin secondary to iatrogenic urological trauma: a safe and effective technique. Urology 2016; 88: 218-221
• 26 Bhatia SS, Dalal R, Gomez C, Narayanan G. Prostatic artery embolization after failed urological interventions for benign prostatic obstruction: a case series of three patients. Cardiovasc Intervent Radiol 2016; 39 (08) 1203-1208
• 27 Malling B, Røder MA, Brasso K, Forman J, Taudorf M, Lönn L. Prostate artery embolisation for benign prostatic hyperplasia: a systematic review and meta-analysis. Eur Radiol 2019; 29 (01) 287-298
• 28 Picel AC, Hsieh TC, Shapiro RM, Vezeridis AM, Isaacson AJ. Prostatic artery embolization for benign prostatic hyperplasia: patient evaluation, anatomy, and technique for successful treatment. Radiographics 2019; 39 (05) 1526-1548
• 29 Bilhim T, Pisco J, Pinheiro LC. Prostatic artery embolization: patient evaluation and technical aspects. Tech Vasc Interv Radiol 2015; 18 (01) 3-10
• 30 Tanguay S, Awde M, Brock G. et al. Diagnosis and management of benign prostatic hyperplasia in primary care. Can Urol Assoc J 2009; 3 (3, suppl 2): S92-S100
• 31 APereira J, Bilhim T, Duarte M, Rio Tinto H, Fernandes L, Martins Pisco J. Patient selection and counseling before prostatic arterial embolization. Tech Vasc Interv Radiol 2012; 15 (04) 270-275
• 32 Sarasin SM, Walton MJ, Singh HP, Clark DI. Can a urinary tract symptom score predict the development of postoperative urinary retention in patients undergoing lower limb arthroplasty under spinal anaesthesia? A prospective study. Ann R Coll Surg Engl 2006; 88 (04) 394-398
• 33 Moon KT, Yoo TK, Kwon SY. et al. A randomised, placebo-controlled, multicentre, Phase 2 clinical trial to evaluate the efficacy and safety of GV1001 in patients with benign prostatic hyperplasia. BJU Int 2018; 122 (02) 283-292
• 34 Hareendran A, Abraham L. Using a treatment satisfaction measure in an early trial to inform the evaluation of a new treatment for benign prostatic hyperplasia. Value Health 2005; 8 (Suppl. 01) S35-S40
• 35 Porst H, Kim ED, Casabé AR. et al; LVHJ study team. Efficacy and safety of tadalafil once daily in the treatment of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: results of an international randomized, double-blind, placebo-controlled trial. Eur Urol 2011; 60 (05) 1105-1113
• 36 Young S, Golzarian J. Prostate embolization: patient selection, clinical management and results. CVIR Endovasc 2019; 2 (01) 7
• 37 Moreira AM, de Assis AM, Carnevale FC, Oliveira DS, Antunes AA. Improvements in irritative versus obstructive symptoms of the International Prostate Symptom Score after prostatic artery embolization in 174 patients, in a single center. Cardiovasc Intervent Radiol 2020; 43 (04) 613-619
• 38 Pisco JM, Bilhim T, Pinheiro LC. et al. Medium- and long-term outcome of prostate artery embolization for patients with benign prostatic hyperplasia: results in 630 patients. J Vasc Interv Radiol 2016; 27 (08) 1115-1122
• 39 Kuntz RM, Ahyai S, Lehrich K, Fayad A. Transurethral holmium laser enucleation of the prostate versus transurethral electrocautery resection of the prostate: a randomized prospective trial in 200 patients. J Urol 2004; 172 (03) 1012-1016
• 40 Ray AF, Powell J, Speakman MJ. et al. Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: an observational study and propensity-matched comparison with transurethral resection of the prostate (the UK-ROPE study). BJU Int 2018; 122 (02) 270-282
• 41 Pisco J, Bilhim T, Pinheiro LC. et al. Prostate embolization as an alternative to open surgery in patients with large prostate and moderate to severe lower urinary tract symptoms. J Vasc Interv Radiol 2016; 27 (05) 700-708
• 42 McWilliams JP, Bilhim TA, Carnevale FC. et al. Society of Interventional Radiology multisociety consensus position statement on prostatic artery embolization for treatment of lower urinary tract symptoms attributed to benign prostatic hyperplasia: from the Society of Interventional Radiology, the Cardiovascular and Interventional Radiological Society of Europe, Société Française de Radiologie, and the British Society of Interventional Radiology: endorsed by the Asia Pacific Society of Cardiovascular and Interventional Radiology, Canadian Association for Interventional Radiology, Chinese College of Interventionalists, Interventional Radiology Society of Australasia, Japanese Society of Interventional Radiology, and Korean Society of Interventional Radiology. J Vasc Interv Radiol 2019; 30 (05) 627-637.e1
• 43 Wong T, Tembelis M, Acharya V, Hoffmann JC. Prostatic artery embolization and sexual function: literature review and comparison to other urologic interventions. Tech Vasc Interv Radiol 2020; 23 (03) 100693
• 44 Antunes AA, Bilhim TA. Prostatic artery embolization for benign prostatic hyperplasia: patient evaluation, anatomy, and technique of embolization. Cardiovasc Intervent Radiol 2016; 39 (05) 585-597
• 45 Maclean D, Harris M, Drake T. et al. Factors predicting a good symptomatic outcome after prostate artery embolisation (PAE). Cardiovasc Intervent Radiol 2018; 41 (08) 1152-1159
• 46 Wang M, Guo L, Duan F. et al. Prostatic arterial embolization for the treatment of lower urinary tract symptoms caused by benign prostatic hyperplasia: a comparative study of medium- and large-volume prostates. BJU Int 2016; 117 (01) 155-164
• 47 Somwaru AS, Metting S, Flisnik LM, Nellamattathil MG, Sharma A, Katabathina VS. Prostate artery embolization has long term efficacy for treatment of severe lower urinary tract symptoms from giant prostatic hyperplasia. BMC Urol 2020; 20 (01) 153
• 48 Wang MQ, Guo LP, Zhang GD. et al. Prostatic arterial embolization for the treatment of lower urinary tract symptoms due to large (>80 mL) benign prostatic hyperplasia: results of midterm follow-up from Chinese population. BMC Urol 2015; 15: 33
• 49 Bagla S, Smirniotopoulos JB, Orlando JC, van Breda A, Vadlamudi V. Comparative analysis of prostate volume as a predictor of outcome in prostate artery embolization. J Vasc Interv Radiol 2015; 26 (12) 1832-1838
• 50 Yu SCH, Cho CCM, Hung EHY. et al. Thickness-to-height ratio of intravesical prostatic protrusion predicts the clinical outcome and morbidity of prostatic artery embolization for benign prostatic hyperplasia. J Vasc Interv Radiol 2019; 30 (11) 1807-1816
• 51 Bilhim T. Prostatic artery embolization and the median lobe: stuck in the middle with you?. J Vasc Interv Radiol 2019; 30 (11) 1817-1819
• 52 Bilhim T, Tinto HR, Fernandes L, Martins Pisco JM, Pisco JM. Prostatic arterial embolization: two years of follow-up. Cardiovasc Intervent Radiol 2013; 36 (02) 432-438
• 53 Singhal S, Sebastian B, Madhurkar R, Uthappa MC. Prostate artery embolisation: an initial experience from an Indian perspective. Pol J Radiol 2018; 83: e554-e559
• 54 Carnevale FC, Moreira AM, Antunes AA. The “PErFecTED technique”: proximal embolization first, then embolize distal for benign prostatic hyperplasia. Cardiovasc Intervent Radiol 2014; 37 (06) 1602-1605
• 55 Bagla S, Rholl KS, Sterling KM. Urodynamic changes in patients with benign prostatic hyperplasia after prostatic artery embolization. J Vasc Interv Radiol 2018; 29 (08) 1122-1129
• 56 Wang Y, Wang MQ, Guo LP, Duan F. Prostatic artery embolization as an alternative to indwelling bladder catheterization to manage benign prostatic hyperplasia in poor surgical candidates: a retrospective study. J Vasc Interv Radiol 2019; 30 (10) 1622-1628
• 57 Carnevale FC, Antunes AA. Prostatic artery embolization: an alternative to transurethral resection of the prostate. Eur Urol 2013; 63 (01) 1-2
• 58 Hashem E, Elsobky S, Khalifa M. Prostate artery embolization for benign prostate hyperplasia review: patient selection, outcomes, and technique. Semin Ultrasound CT MR 2020; 41 (04) 357-365
• 59 Mouli S, Hohlastos E, Salem R. Prostate artery embolization. Semin Intervent Radiol 2019; 36 (02) 142-148
• 60 García Mónaco R, Garategui L, Kizilevsky N, Peralta O, Rodriguez P, Pala- cios-Jaraquemada J. Human cadaveric specimen study of the prostatic arterial anatomy: implications for arterial embolization. J Vasc Interv Radiol 2014; 25: 315-322
• 61 Bilhim T, Pisco JM, Rio Tinto H. et al. Prostatic arterial supply: anatomic and imaging findings relevant for selective arterial embolization. J Vasc Interv Radiol 2012; 23 (11) 1403-1415
• 62 Kurbatov D, Russo GI, Lepetukhin A. et al. Prostatic artery embolization for prostate volume greater than 80 cm3: results from a single-center prospective study. Urology 2014; 84 (02) 400-404
• 63 Carnevale FC, Iscaife A, Yoshinaga EM, Moreira AM, Antunes AA, Srougi M. Transurethral resection of the prostate (TURP) versus original and PErFecTED prostate artery embolization (PAE) due to benign prostatic hyperplasia (BPH): preliminary results of a single center, prospective, urodynamic-controlled analysis. Cardiovasc Intervent Radiol 2016; 39 (01) 44-52
• 64 Gonçalves OM, Carnevale FC, Moreira AM, Antunes AA, Rodrigues VC, Srougi M. Comparative study using 100-300 versus 300-500 μm microspheres for symptomatic patients due to enlarged-BPH prostates. Cardiovasc Intervent Radiol 2016; 39 (10) 1372-1378
• 65 Bilhim T, Pisco J, Campos Pinheiro L. et al. Does polyvinyl alcohol particle size change the outcome of prostatic arterial embolization for benign prostatic hyperplasia? Results from a single-center randomized prospective study. J Vasc Interv Radiol 2013; 24 (11) 1595-602.e1
• 66 Bhatia S, Sinha V, Bordegaray M, Kably I, Harward S, Narayanan G. Role of coil embolization during prostatic artery embolization: incidence, indications, and safety profile^☆ . J Vasc Interv Radiol 2017; 28 (05) 656-664.e3
• 67 Carnevale FC, Moreira AM, de Assis AM. et al. Prostatic artery embolization for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: 10 years' experience. Radiology 2020; 296 (02) 444-451
• 68 Uflacker A, Haskal ZJ, Bilhim T, Patrie J, Huber T, Pisco JM. Meta-analysis of prostatic artery embolization for benign prostatic hyperplasia. J Vasc Interv Radiol 2016; 27 (11) 1686-1697.e8
• 69 Feng S, Tian Y, Liu W. et al. Prostatic arterial embolization treating moderate-to-severe lower urinary tract symptoms related to benign prostate hyperplasia: a meta-analysis. Cardiovasc Intervent Radiol 2017; 40 (01) 22-32
• 70 de Assis AM, Moreira AM, de Paula Rodrigues VC. et al. Prostatic artery embolization for treatment of benign prostatic hyperplasia in patients with prostates > 90 g: a prospective single-center study. J Vasc Interv Radiol 2015; 26 (01) 87-93
• 71 Patel NR, Elterman DS, Thulasidasan N. et al. Initial Canadian experience of prostate artery embolization for symptomatic benign prostatic hyperplasia: midterm outcomes. Can Assoc Radiol J 2021; 72 (04) 876-882
• 72 Salem R, Hairston J, Hohlastos E. et al. Prostate artery embolization for lower urinary tract symptoms secondary to benign prostatic hyperplasia: results from a prospective FDA-approved investigational device exemption study. Urology 2018; 120: 205-210
• 73 Wang MQ, Wang Y, Yan JY. et al. Prostatic artery embolization for the treatment of symptomatic benign prostatic hyperplasia in men ≥75 years: a prospective single-center study. World J Urol 2016; 34 (09) 1275-1283
• 74 Maclean D, Harris M, Drake T, Maher J, Little MW. Prostate artery embolization in the treatment of benign prostatic hyperplasia: single-center outcomes of technical and clinical success. J Vasc Interv Radiol 2020; 31 (02) 289-297
• 75 Parikh N, Acharya V, Bhatia S. Prostate artery embolization - adverse events and peri-procedural management. Tech Vasc Interv Radiol 2020; 23 (03) 100692
• 76 Abt D, Hechelhammer L, Müllhaupt G. et al. Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: randomised, open label, non-inferiority trial. BMJ 2018; 361: k2338
• 77 Insausti I, Sáez de Ocáriz A, Galbete A. et al. Randomized comparison of prostatic artery embolization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia. J Vasc Interv Radiol 2020; 31 (06) 882-890
• 78 Pisco JM, Bilhim T, Costa NV. et al. Randomised clinical trial of prostatic artery embolisation versus a sham procedure for benign prostatic hyperplasia. Eur Urol 2020; 77 (03) 354-362
• 79 Jiang YL, Qian LJ. Transurethral resection of the prostate versus prostatic artery embolization in the treatment of benign prostatic hyperplasia: a meta-analysis. BMC Urol 2019; 19 (01) 11
• 80 Xiang P, Guan D, Du Z. et al. Efficacy and safety of prostatic artery embolization for benign prostatic hyperplasia: a systematic review and meta-analysis of randomized controlled trials. Eur Radiol 2021; 31 (07) 4929-4946
• 81 Cardarelli-Leite L, de Assis AM, Moreira AM. et al. Impact of 5-alpha-reductase inhibitors use at the time of prostatic artery embolization for treatment of benign prostatic obstruction. J Vasc Interv Radiol 2019; 30 (02) 228-232
• 82 Sapoval M, Thiounn N, Descazeaud A. et al; PARTEM study group. Prostatic artery embolisation versus medical treatment in patients with benign prostatic hyperplasia (PARTEM): a randomised, multicentre, open-label, phase 3, superiority trial. Lancet Reg Health Eur 2023; 31: 100672
• 83 Seizilles de Mazancourt E, Pagnoux G, Codas Duarte R. et al. Prostatic arterial embolization versus holmium laser enucleation of the prostate: 1-year outcomes. World J Urol 2023; 41 (01) 151-157
• 84 Bhatia A, Porto JG, Maini A. et al. One-year outcomes after prostate artery embolization versus laser enucleation: a network meta-analysis. BJUI Compass 2023; 5 (02) 189-206
• 85 Sajan A, Mehta T, Desai P, Isaacson A, Bagla S. Minimally invasive treatments for benign prostatic hyperplasia: systematic review and network meta-analysis. J Vasc Interv Radiol 2022; 33 (04) 359-367.e8
• 86 Tapping CR, Macdonald A, Hadi M. et al. Prostatic artery embolization (PAE) for benign prostatic hyperplasia (BPH) with haematuria in the absence of an upper urinary tract pathology. Cardiovasc Intervent Radiol 2018; 41 (08) 1160-1164
• 87 Tapping CR, Crew J, Proteroe A, Boardman P. Prostatic artery embolization (PAE) for prostatic origin bleeding in the context of prostate malignancy. Acta Radiol Open 2019; 8 (06) 2058460119846061
• 88 ClinicalTrials.gov Identifier: NCT04563221(ongoing clinical trial)
• 89 Tapping CR, Little MW, Macdonald A. et al. The STREAM trial (prostatic artery embolization for the treatment of benign prostatic hyperplasia) 24-month clinical and radiological outcomes. Cardiovasc Intervent Radiol 2021; 44 (03) 436-442